Q4 2021 Arbutus Biopharma Corp Earnings Call Transcript
Good day, and thank you for standing by. Welcome to the Arbutus Biopharma Corporation Fourth Quarter and Year-end 2021 Financial Results and Corporate Update Conference Call. (Operator Instructions)
I would now like to hand the conference to your speaker today, Lisa Caperelli, Vice President of Investor Relations. Please go ahead.
Thank you, Katherine. Good morning, everyone, and thank you for joining Arbutus' fourth quarter and year-end financial and business update call. Joining me today from the Arbutus executive team are Bill Collier, President and Chief Executive Officer; David Hastings, Chief Financial Officer; Dr. Gaston Picchio, Chief Development Officer; and Dr. Michael Sofia, Chief Scientific Officer. Bill will begin with a review of recent accomplishments and clinical developments, followed by Dave Hastings who will provide a review of the company's fourth quarter and year-end financial results.
After opening remarks, we will open the call up for Q&A. Gaston Picchio
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
